Table 3.
Baseline characteristics of participants, APFHL study 2020.
| Total | APFHL + Food Rx Group | Food Rx-Only Group | ||
|---|---|---|---|---|
| (n = 114) | (n = 35) | (n = 79) | ||
| Demographics: | mean (±SD 1) | p-value 2 | ||
| Age | 55.9 (±8.9) | 57.0 (±10.3) | 55.4 (±8.2) | 0.377 |
| N (%) | p-value 3 | |||
| Gender | ||||
| Female | 78 (68.4) | 28 (80.0) | 50 (63.3) | 0.077 |
| Male | 36 (31.6) | 7 (20.0) | 29 (36.7) | |
| Race/ethnicity | ||||
| Hispanic, Latino American, or Spanish origin | 94 (86.2) | 27 (79.4) | 67 (89.3) | 0.049 * |
| Non-Hispanic | 15 (13.8) | 7 (20.6) | 8 (10.7) | |
| Food insecurity status | ||||
| positive | 73 (65.2) | 24 (70.6) | 49 (62.8) | 0.428 |
| negative | 39 (34.8) | 10 (29.4) | 29 (37.2) | |
| Biometric Outcomes: | mean (±SD 1) | p-value 2 | ||
| HbA1c | 9.54 (2.15) | 9.52 (2.13) | 9.54 (2.17) | 0.954 |
| SBP 4 | 133.08 (19.02) | 132.52 (22.80) | 133.31 (17.42) | 0.851 |
| DBP 5 | 74.96 (10.64) | 72.97 (12.25) | 75.77 (9.88) | 0.233 |
| BMI 6 | 33.96 (7.90) | 35.82 (9.45) | 33.23 (7.15) | 0.149 |
| HbA1c | ||||
| Prediabetes | 1 (0.09) | 0 (0.0) | 1 (1.4) | 0.728 |
| Diabetes | ||||
| 6.5 to <9% | 52 (48.2) | 15 (45.5) | 37 (49.3) | |
| ≥9% | 55 (50.9) | 18 (54.5) | 37 (49.3) | |
| Blood Pressure | ||||
| Normal | 21 (21.0) | 8 (27.6) | 13 (18.3) | 0.261 |
| Elevated | 15 (15.0) | 6 (20.7) | 9 (12.7) | |
| High Blood Pressure | 64 (64.0) | 15 (51.7) | 49 (69.0) | |
| BMI | ||||
| Normal | 5 (5.2) | 1 (3.7) | 4 (5.8) | 0.722 |
| Overweight | 33 (34.4) | 8 (29.6) | 25 (36.2) | |
| Obese | 58 (60.4) | 18 (66.7) | 40 (58.0) | |
1 Standard deviation. 2 p-value was obtained from two-sample independent t-test 3 p-values were obtained from chi-square tests. 4 SBP stands for systolic blood pressure. 5 DBP stands for diastolic blood pressure. 6 BMI stands for body mass index. * significant at p < 0.05.